Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Carcinoma × Vaccines × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Neoplasms 2 Neuroectodermal Tumors, Primitive 1 Neoplasm Metastasis 1 Medulloblastoma 1 Glioma 1 Carcinoma 1 Breast Neoplasms, Male 1 Breast Neoplasms 1

Interventions

Carboplatin 6 pembrolizumab 4 Sorafenib 3 Pemetrexed 3 Paclitaxel 3 Gemcitabine 3 Cyclophosphamide 3 seocalcitol 2 selinexor 2 patritumab 2 osimertinib 2 liposomal doxorubicin 2 interferon gamma-1b 2 fludarabine 2 Sunitinib 2 Radiotherapy, Intensity-Modulated 2 Radiotherapy 2 Irinotecan 2 Interleukin-2 2 Erlotinib Hydrochloride 2 DNA 2 Cisplatin 2 Celecoxib 2 Capecitabine 2 Bleomycin 2 Albumin-Bound Paclitaxel 2 130-nm albumin-bound paclitaxel 2 volociximab 1 thioredoxin reductase inhibitor AM12 1 sonidegib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00684294 2020-03-02

Auto TAG

Mary Crowley Medical Research Center

Phase 1 Terminated

Carcinoma, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡